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Background: Successful percutaneous coronary intervention (PCI) of chronic total
occlusions (CTO) is associated with improvement in angina, left ventricular function, and
increased survival. However, the safety profile of CTO PCI has been poorly studied.
Methods: We conducted a systematic review and meta-analysis of 65 studies published
between 2000 and 2011 reporting procedural complications of CTO PCI. Data on the
frequency of death, emergent coronary artery bypass graft surgery (CABG), stroke,
myocardial infarction (MI), perforation, tamponade, stent thrombosis, major vascular or
bleeding events, contrast nephropathy, and radiation skin injury were collected.
Results: We aggregated data from 19,191 patients who underwent CTO PCI of 20,050
target vessels. Mean age was 62.4 years, 82% were men, and 15% had prior CABG. The
CTO artery was the right coronary (42%), left anterior descending (34%), circumflex
(21%) or a bypass graft (0.6%). Angiographic success was achieved in 76.5% of patients.
The incidence of procedural complications is shown in the Table. Compared to
angiographically successful procedures, unsuccessful procedures had higher rates of death
(0.42% vs 1.54%, p0.0001), perforations (3.65% vs 10.70%, p0.0001), and tampon-
ade (0% vs 1.65%, p0.0001). In patients with successful procedures there was a trend
towards lower rates of emergent CABG (0.04% vs 0.17%, p0.77), stroke (0.14% vs
0.54%, p0.15), and Q wave MI (0.26% vs 0.54%, p0.26). In 886 lesions treated with
a retrograde approach, the success rate was 79.8% with no deaths and low rates of
emergent CABG (0.17%) and tamponade (1.2%).
Conclusions: This systematic review and meta-analysis of CTO PCI complications
demonstrates low risk for major procedural complications suggesting that CTO PCI may
be associated with a favorable risk/benefit profile.
Outcome Studies Patients Lesions
Event
rate,
n (%)
Event
rate 95%
CI
Death 65 19191 20050 64
(0.33%)
0.25 –
0.43%
Emergent coronary
artery bypass graft
surgery
65 19191 20050 23
(0.12%)
0.08 –
0.18%
Stroke 65 19191 20050 12
(0.06%)
0.03 –
0.11%
Myocardial
infarction
54 15057 15519 413
(2.7%)
2.5 –
3.0%
Q Wave
myocardial
infarction
45 12692 13034 29
(0.2%)
0.2 –
0.3%
Coronary
perforation (per
lesion)
50 13365 14106 481
(3.4%)
3.1 –
3.7%
Tamponade 53 11841 12545 65
(0.5%)
0.4 –
0.7%
Acute Stent
thrombosis
24 7331 7907 21
(0.3%)
0.2 –
0.4%
Vascular
complication
15 7909 8054 44
(0.6%)
0.4 –
0.7%
Major bleed 14 7716 7886 58
(0.8%)
0.6 – 1%
Contrast
nephropathy
13 4796 4995 165
(3.4%)
2.9 –
4.0%
Radiation injury 7 2857 2979 3
(0.1%)
0.02 –
0.3%
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Background: We conducted a randomized comparison of Sirolimus-eluting stents (SES)
with two Zotarlimus-eluting stents (ZES; Endeavor and Resolute) after successful
recanalization of total coronary occlusions (TCO). At 9 months, SES were superior to
Endeavor ZES and comparable to Resolute ZES with regard to angiographic late lumen
loss. We do not know whether this superior angiographic outcome translates into
improved clinical outcomes at two-year follow-up.
Methods: We performed clinical follow-up after two years in the PRISON III trial
comparing SES versus ZES (Endeavor or Resolute) in two study phases. In the first phase,
51 patients were randomized to receive SES and 46 Endeavor ZES. In the second phase,
103 and 104 patients were randomized to SES or Resolute ZES, respectively.
Results: The table shows the occurrence of clinical events at two-year. The right panel
demonstrates the SES versus the Endeavor ZES comparison and the left panel SES versus
the Resolute ZES. There was a trend towards less target lesion revascularisation (TLR;
9.8% vs. 17.4%, p0.43) and target vessel failure (TVF; 11.8% vs. 17.4%, p0.62) with
SES compared to Endeavor ZES. No differences in TLR and TVF were observed between
SES and Resolute ZES (6.8% vs. 4.8%, p0.75; 6.8% vs. 6.7%, p0.80). There were
only a few cases of cardiac death, myocardial infarctions and probable or definitive stent
thrombosis.
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